Barbara Kosacz
Director, XOMA Royalty Corp.
Companies
- LeonaBio, Inc.Board member Mar 8, 2021 to now1
- Kronos Bio, Inc.Chief operating officer Oct 8, 2020 to now2
- Kronos Bio, Inc.General counsel Oct 8, 2020 to now2
- XOMA Royalty CorpBoard member Jan 3, 2019 to now3
- CERO THERAPEUTICS HOLDINGS, INC.Board member Oct 5, 2021 to Feb 16, 20244
- eFFECTOR Therapeutics, Inc.Board member Jan 7, 2021 to Jan 14, 20215
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- CERO THERAPEUTICS HOLDINGS, INC. CERO5,828 shares6$35 at $0.01Feb 14, 2024
- XOMA Royalty Corp0 shares7Jul 14, 2026
- Kronos Bio, Inc.928,966 shares8Jan 4, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 14, 2026Other 6,269 shares of XOMA Royalty Corp7
- May 21, 2026Granted 3,586 shares of XOMA Royalty Corp9
- May 21, 2025Granted 5,971 shares of XOMA Royalty Corp10
- May 21, 2025Granted 5,971 shares of XOMA Royalty Corp11
- Feb 14, 2024Other 5,828 shares of CERO THERAPEUTICS HOLDINGS, INC.6
- Jan 4, 2024Sold 10,676 shares at $1.18 of Kronos Bio, Inc.8
- Feb 15, 2023Granted 138,911 shares of Kronos Bio, Inc.12
- Jul 25, 2022Granted 53,600 shares of Kronos Bio, Inc.13
- Feb 15, 2022Granted 53,600 shares of Kronos Bio, Inc.14
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARLeonaBio, Inc., Board member
- 2
- 3SEC EDGARXOMA Royalty Corp, Board member
- 4
- 5
- 6
- 7
- 8
- 9SEC EDGARForm 4 filed May 26, 2026
- 10SEC EDGARForm 4 filed May 23, 2025
- 11SEC EDGARForm 4 filed May 23, 2025
- 12SEC EDGARForm 4 filed Feb 17, 2023
- 13SEC EDGARForm 4 filed Jul 27, 2022
- 14SEC EDGARForm 4 filed Feb 17, 2022